-plc-logo-1200x675.JPG&w=240&h=240&zc=2){kind=logo}
KalVista Pharmaceuticals (NASDAQ:KALV) Given Buy Rating at Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) in a report released on Wednesday,Benzinga reports. The brokerage currently has a $28.00 price target on the specialty pharmaceutical company’s stock. Several other research analysts have also issued reports on KALV. TD Cowen started coverage on KalVista Pharmaceuticals […]
Needham & Company LLC reissued their buy rating on shares of KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) in a report released on Wednesday,Benzinga reports. The brokerage currently has a $28.00 price target on the specialty pharmaceutical company’s stock. Several other research analysts have also issued reports on KALV. TD Cowen started coverage on KalVista Pharmaceuticals […]
